These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 749812)

  • 41. Safety and Immunogenicity of a 4-Component Toxoid-Based
    Venkatasubramaniam A; Liao G; Cho E; Adhikari RP; Kort T; Holtsberg FW; Elsass KE; Kobs DJ; Rudge TL; Kauffman KD; Lora NE; Barber DL; Aman MJ; Karauzum H
    Front Immunol; 2021; 12():621754. PubMed ID: 33717122
    [No Abstract]   [Full Text] [Related]  

  • 42. [Various aspects of the specific immunological effect of staphylococcal vaccine justifying the use of autovaccines. III. Evaluation of the chemotactic properties of staphylococci in vivo].
    Giedrys-Galant S
    Med Dosw Mikrobiol; 1987; 39(4):213-22. PubMed ID: 3437782
    [No Abstract]   [Full Text] [Related]  

  • 43. [Antibodies against staphylococcal nuclease--titres of persons with and without staphylococcal infections (author's transl)].
    Tiesler E; Hasler W
    Immun Infekt; 1977 Jun; 5(3):114-8. PubMed ID: 885579
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospects for a MRSA vaccine.
    Lindsay JA
    Future Microbiol; 2007 Feb; 2(1):1-3. PubMed ID: 17661669
    [No Abstract]   [Full Text] [Related]  

  • 45. Ovine opsonins for Staphylococcus aureus cell wall and pseudocapsule.
    Watson DL
    Res Vet Sci; 1989 Jan; 46(1):84-9. PubMed ID: 2784216
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Immunostimulating activity of antigenic complexes isolated from various Staphylococcus strains].
    Egorova NB; Korzaia LI; Efremova VN; Mashilova GM; Gladus MA
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Aug; (8):102-7. PubMed ID: 7180258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new view on development of a Staphylococcus aureus vaccine: insights from mice and men.
    Spellberg B; Daum R
    Hum Vaccin; 2010 Oct; 6(10):857-9. PubMed ID: 20930569
    [No Abstract]   [Full Text] [Related]  

  • 48. Considering the 'Alternatives' for Next-Generation Anti-Staphylococcus aureus Vaccine Development.
    O'Brien EC; McLoughlin RM
    Trends Mol Med; 2019 Mar; 25(3):171-184. PubMed ID: 30713007
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Experimental, clinical and immunologic assessment of acellular staphylococcal vaccine "Staphylovac"].
    Egorova NB; Efremova VN; Kurbatova EA; Gruber IM
    Zh Mikrobiol Epidemiol Immunobiol; 2008; (6):102-8. PubMed ID: 19186558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deciphering the significance of the T-cell response to Staphylococcus aureus.
    Bekeredjian-Ding I
    Future Microbiol; 2017 Sep; 12():1023-1026. PubMed ID: 28748708
    [No Abstract]   [Full Text] [Related]  

  • 51. [An experimental study of humoral immunity factors in immunization with a cell-free staphylococcal vaccine].
    Kuz'mina LA; Kozlova NN
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):44-5. PubMed ID: 8553749
    [No Abstract]   [Full Text] [Related]  

  • 52. Expectations regarding vaccines and immune therapies directed against Staphylococcus aureus alpha-hemolysin.
    Kernodle DS
    J Infect Dis; 2011 Jun; 203(11):1692-3; author reply 1693-4. PubMed ID: 21593000
    [No Abstract]   [Full Text] [Related]  

  • 53. A MRSA-terious enemy among us: boosting MRSA vaccines.
    Kobayashi SD; DeLeo FR
    Nat Med; 2011 Feb; 17(2):168-9. PubMed ID: 21297611
    [No Abstract]   [Full Text] [Related]  

  • 54. Cellular basis for differences in humoral immune responses of sheep immunized with living or killed Staphylococcus aureus vaccines.
    Kennedy JW; Watson DL
    Aust J Exp Biol Med Sci; 1982 Dec; 60(6):643-54. PubMed ID: 6892102
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Antigen-specific and antigen-nonspecific reactions of the immunity system in vaccination with a purified concentrated staphylococcal anatoxin].
    Katkhanov AM; Borovikov OV; Prokhorov VIa; Ratgauz GL; Vasil'eva IV
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Mar; (3):34-8. PubMed ID: 3591123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immunity indices under immunotherapy of surgical staphylococcal infection in children].
    Babii ZM; Kaplan VM
    Mikrobiol Zh; 1975; 37(4):476-81. PubMed ID: 55947
    [No Abstract]   [Full Text] [Related]  

  • 57. A path forward for Staphylococcus aureus vaccine development.
    Fritz SA; Bubeck Wardenburg J
    J Exp Med; 2024 Oct; 221(10):. PubMed ID: 39150449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials.
    Bagnoli F; Bertholet S; Grandi G
    Front Cell Infect Microbiol; 2012; 2():16. PubMed ID: 22919608
    [No Abstract]   [Full Text] [Related]  

  • 59. [Heterologous antistaphylococcal gamma-globulin in the treatment of staphylococcal sepsis].
    Shubik IuG; Nemchenko VI
    Vestn Khir Im I I Grek; 1979 Apr; 122(4):46-50. PubMed ID: 87058
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of acellular staphylococcal vaccine "Staphylovac" on several indicators of immune system in mice].
    Kuz'menko OM; Akhmatova NK; Gruber IM
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (3):32-7. PubMed ID: 19621816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.